Abstract
Mycotic aneurysms although rare can be devastating. We encountered a dialysis patient with rapidly expanding distal aortic arch aneurysm who underwent axilloaxillary bypass and thoracic endovascular aortic repair (TEVAR). Three months later, he suffered mycotic aneurysm rupture for which redo TEVAR was performed. Antibiotic therapy was discontinued 16 weeks after the second operation, and renal transplantation was performed 6 months later. Dialysis was discontinued in the patient without infection recurrence.
Copyright © 2016 Elsevier Inc. All rights reserved.
MeSH terms
-
Aged
-
Aneurysm, Infected / diagnostic imaging
-
Aneurysm, Infected / microbiology
-
Aneurysm, Infected / surgery*
-
Anti-Bacterial Agents / therapeutic use
-
Aortic Aneurysm, Thoracic / complications
-
Aortic Aneurysm, Thoracic / diagnostic imaging
-
Aortic Aneurysm, Thoracic / surgery*
-
Aortic Rupture / diagnostic imaging
-
Aortic Rupture / microbiology
-
Aortic Rupture / surgery*
-
Aortography / methods
-
Bacteroides Infections / diagnostic imaging
-
Bacteroides Infections / microbiology
-
Bacteroides Infections / surgery*
-
Bacteroides fragilis / isolation & purification*
-
Blood Vessel Prosthesis Implantation / adverse effects*
-
Computed Tomography Angiography
-
Endovascular Procedures / adverse effects*
-
Humans
-
Immunosuppressive Agents / therapeutic use
-
Kidney Failure, Chronic / complications
-
Kidney Failure, Chronic / therapy
-
Kidney Transplantation
-
Male
-
Renal Dialysis
-
Reoperation
-
Staphylococcal Infections / diagnostic imaging
-
Staphylococcal Infections / microbiology
-
Staphylococcal Infections / surgery*
-
Time Factors
-
Treatment Outcome
Substances
-
Anti-Bacterial Agents
-
Immunosuppressive Agents